Evidence map›Paper›PMID 30824863›Full record

ArticleScientific reports2019

Selecting variants of unknown significance through network-based gene-association significantly improves risk prediction for disease-control cohorts.

Anastasis Oulas, George Minadakis, Margarita Zachariou, George M Spyrou

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. The Role of Genetics in the Management of Heart Failure Patients.International journal of molecular sciences · 2023
    Review
  2. Review
  3. Targeting mutations in cancer.The Journal of clinical investigation · 2022
    Review
  4. Review
  5. Article
  6. Article
  7. How Functional Genomics Can Keep Pace With VUS Identification.Frontiers in cardiovascular medicine · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anastasis OulasThe Cyprus Institute of Neurology & Genetics, Bioinformatics Group, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus. anastasioso@cing.ac.cy.
George MinadakisThe Cyprus Institute of Neurology & Genetics, Bioinformatics Group, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus.
Margarita ZachariouThe Cyprus Institute of Neurology & Genetics, Bioinformatics Group, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus.
George M SpyrouThe Cyprus Institute of Neurology & Genetics, Bioinformatics Group, 6 International Airport Avenue, 2370 Nicosia, Cyprus, P.O.Box 23462, 1683, Nicosia, Cyprus.ORCID 0000-0002-2470-3363

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Variants of unknown/uncertain significance (VUS) pose a huge dilemma in current genetic variation screening methods and genetic counselling. Driven by methods of next generation sequencing (NGS) such as whole exome sequencing (WES), a plethora of VUS are being detected in research laboratories as well as in the health sector. Motivated by this overabundance of VUS, we propose a novel computational methodology, termed VariantClassifier (VarClass), which utilizes gene-association networks and polygenic risk prediction models to shed light into this grey area of genetic variation in association with disease. VarClass has been evaluated using numerous validation steps and proves to be very successful in assigning significance to VUS in association with specific diseases of interest. Notably, using VUS that are deemed significant by VarClass, we improved risk prediction accuracy in four large case-studies involving disease-control cohorts from GWAS as well as WES, when compared to traditional odds ratio analysis. Biological interpretation of selected high scoring VUS revealed interesting biological themes relevant to the diseases under investigation. VarClass is available as a standalone tool for large-scale data analyses, as well as a web-server with additional functionalities through a user-friendly graphical interface.

Indexed as

Gene Regulatory NetworksGenetic Predisposition to DiseaseGenetic VariationGenotypeHigh-Throughput Nucleotide SequencingModels, GeneticDNA Mutational AnalysisGenome-Wide Association StudyHumans

Identifiers

PMID30824863
PMCPMC6397233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.